Sorry, you need to enable JavaScript to visit this website.
Latest News
September 09, 2020
Not intended for U.S. and UK Media
New England Journal of Medicine publishes final overall survival data for Nubeqa™ (darolutamide) showing treatment significantly extends life in men with non-metastatic prostate cancer
September 09, 2020
Bayer collaborates with Recursion to strengthen digital drug discovery and advance new therapies for fibrotic diseases
September 09, 2020
Not intended for U.S. and UK Media
Bayer completes acquisition of UK-based biotech company KaNDy Therapeutics Ltd.
September 08, 2020
Not intended for U.S. and UK Media
Bayer to showcase new data from evolving Oncology portfolio at ESMO Virtual Congress 2020
August 28, 2020
Not intended for U.S. and UK Media
Bayer submits vericiguat for marketing authorization in China for the treatment of chronic heart failure
Global Health Policy Blog
Current Topics
All